Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.00
-0.37 (-1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AAPG Market Cap
AAPG has a market cap or net worth of $2.16 billion as of April 28, 2026. Its market cap has increased by 9.25% in one year.
Market Cap
2.16B
Enterprise Value
2.09B
1-Year Change
9.25%
Ranking
Category
Stock Price
$23.00
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $2.16B, an increase of 289.19%. That is a compound annual growth rate of 42.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.17B | -12.34% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 2.36B |
| Mineralys Therapeutics | 2.27B |
| Definium Therapeutics | 2.24B |
| Tyra Biosciences | 2.24B |
| Adaptive Biotechnologies | 2.18B |
| Sarepta Therapeutics | 2.13B |
| Aurinia Pharmaceuticals | 2.12B |
| Zymeworks | 2.07B |